Risk of tuberculosis in Korean inflammatory bowel disease patients treated with Tumor Necrosis Factor-a (TNF-a) blockers
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0001204
- Lead Sponsor
- Kyung Hee University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
all IBD patients treated with TNF-a blockers at 8 academic referral hospitals in Korea
Exclusion Criteria
non-Koreans
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantification of the incidence rate of TB in IBD patients treated with TNF-a blockers and compared that with general population rates
- Secondary Outcome Measures
Name Time Method clinical characteristics, including outcomes, and the risk factors of TB in IBD patients receiving TNF-a blocker therapy;aimed to investigate how latent TB screening is being carried out in actual clinical settings and its efficacy